Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin in bronchiolitis obliterans syndrome after lung transplantation
ISRCTN36220396Phase 4Completed
- Sponsor
- KU Leuven
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Bronchiolitis Obliterans Syndrome (BOS) comparing Azithromycin + standard of care with Placebo + standard of care (2 arms). Primary endpoints: Prevalence of bronchiolitis obliterans syndrome and Overall survival. Started Sep 2005; status: completed.
02
Drugs
azithromycin
03
Conditions
Bronchiolitis Obliterans Syndrome (BOS)
Beyond the preview
Go deeper on ISRCTN36220396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN36220396.